Impact Factor
2.91
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.19
102 total citations
h5-index
14
h5 depth signal
Cited share
77.1%
37 of 48
Total citations
102
Citation footprint
Metric signal
2.04
External metric anchor
Self-citation
3.9%
4 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
India
164
Iran
31
United States
27
Nigeria
18
Italy
15
Citing Fields of Research
Neurodegenerative Disorders
119
Neurosciences
70
Phytochemicals
55
Brain Neurological Disorders
36
Molecular Pharmacology
28
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
615
Articles tracked across the journal lifetime
Indexed publication set
48
37 cited publications
Last 12 months
60
5.0 publications/month
Open access share
0.0%
0 OA publications in the last year
Leading citing country
India
164 citing publications
Leading citing field
Neurodegenerative Disorders
119 citing publications
Latest tracked publication
6 October 2026
10 recent records available
Coverage & Indexing History
v9n1, Mar. 2009-
v9n1, Mar. 2009-
Research Focus & Classification
Indexed Subjects
Neurodegenerative Disorders
Phytochemicals
Neurosciences
Brain Neurological Disorders
Drug Delivery Systems
Broad Categories
Chemistry
Neurology
Pharmacology
Neurodegenerative Disorders
Phytochemicals
Brain Neurological Disorders
Agrochemicals & Ground Poisoning
Neurosciences
Drug Delivery Systems
MeSH Descriptors
Central Nervous System Agents
Central Nervous System
Chemistry, Pharmaceutical
Drug Design
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.2174/0118715249481290260916055723
Open DOI
MAO-B Inhibitory and Antioxidant Properties of Flavonoids from Chenopodium album: Implications for Neuroprotection
Introduction: Neurodegenerative diseases, especially Parkinson’s disease, have been linked with oxidative stress, mitochondrial malfunction, neuroinflammation, and dopamine metabolism impairment. On the other hand, C. album is a medicina...
02
DOI 10.2174/0118715249434117260910074306
Open DOI
Mechanistic Insights into the Neuroprotective Potential of Luteolin: An Overview
Neurodegenerative disorders, such as Alzheimer's and Parkinson's diseases, are characterized by pathologies such as oxidative stress, neuroinflammation, mitochondrial dysfunction, and protein aggregation. Luteolin, a natural flavonoid, i...
03
DOI 10.2174/0118715249476221260930032152
Open DOI
Neuroprotective Profile of Dexpanthenol in Traumatic Spinal Cord Injury: A Focus on the Inhibition of Ferroptotic Cell Death
Introduction: Traumatic spinal cord injury (TSCI) is a catastrophic insult to the central nervous system (CNS) and often leaves patients with profound, long-term neurological disability. In this study, we evaluated whether dexpanthenol, ...
04
DOI 10.2174/0118715249512928260918130405
Open DOI
Neuroprotective Effect of Imeglimin Hydrochloride on H2O2-Induced SH-SY5Y Cells
Introduction: Alzheimer’s disease is characterized by cognitive decline accompanied by the degeneration of cholinergic neurons. Notably, ROS make neurons more vulnerable to oxidative stress-induced damage and functional impairment in the...
05
DOI 10.2174/0118715249480900260920063703
Open DOI
Advancing Understanding of TBI Injury: Pathophysiological Mechanism, Secondary Damage, and Emerging Neuroprotective Strategies
Traumatic brain injury (TBI) is among the leading causes of mortality and long-term disability worldwide, particularly in younger populations. Despite extensive research, there are currently no clinically effective neuroprotective therap...
06
DOI 10.2174/0118715249471785260829144035
Open DOI
Current Insights on CNS-Targeted Matrix Metalloproteinase Inhibitors for the Management of Alzheimer’s Disease
Matrix metalloproteinases, or MMPs, are enzymes that depend on zinc and play a key role in remodelling the extracellular matrix as well as regulating neuroinflammation within the central nervous system. There’s growing evidence that when...
07
DOI 10.2174/0118715249465563260901043608
Open DOI
Novel Biological Mechanisms in MDD Pathophysiology: Emerging Roles of Glymphatic Dysfunction, Ferroptosis, and Extracellular Vesicles (EVs)
Major Depressive Disorder (MDD) is one of the world’s most disabling conditions. The traditional model focuses on monoaminergic imbalance, neurotrophic deficits, and hypothalamic- pituitary-adrenal (HPA) axis dysfunction. However, this m...
08
DOI 10.2174/0118715249497051260829094309
Open DOI
Beyond the Single-Target Approach: Polypharmacology and Multi-Target Therapeutics in Alzheimer’s Disease
Alzheimer's disease (AD) is a multifactorial neurodegenerative disorder characterized by amyloid-beta aggregation, tau pathology, oxidative stress, neuroinflammation, mitochondrial dysfunction, and synaptic degeneration. The limited clin...
09
DOI 10.2174/0118715249421329260806034835
Open DOI
Effect of Green-Synthesized Curcumin-Coated Silver Nanoparticles on the Hippocampal Tissue in Chlorpyrifos-Exposed Developing Male Rats
Introduction: Pubertal modifications are likely to affect various regions of the central nervous system (CNS) structure and functioning by multiple mechanisms. The development of the CNS during this period makes this system highly suscep...
10
DOI 10.2174/0118715249421795251208222103
Open DOI
Chalcone–Arylpiperazine Hybrids as Potential Antianxiety Agents: Synthesis, Biological Evaluation, Molecular Modeling, and Network Pharmacology Studies
Introduction: Anxiety disorders are among the most prevalent mental health conditions, yet recent drug development has yielded few novel antianxiety agents. This study explores chalcone- arylpiperazine hybrids as potential scaffolds for ...
Bibliographical & Catalog Notes
Title from cover.
Also issued online.